Skip to main content

Table 2 The baseline characteristics of the groups with and without diabetes

From: Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus

  Diabetic (n = 1163) Non-diabetic (n = 2478) p value for trend
Age, years 62.10 (27–92) 61.10 (28–95) 0.019
Male, n% 809 (69.56) 1823 (73.57) 0.017
BMI(kg/m2) 26.06 ± 3.40 25.45 ± 3.56 0.000
Risk factors for atherosclerosis    
 Current smokers, n (%) 494 (42.48) 1174 (47.38) 0.007
 Hypertension, n (%) 839 (72.14) 1531 (61.78) 0.000
 Hyperlipidemia, n (%) 342 (29.41) 778 (31.40) 0.234
Cardiac history    
 Previous MI, n (%) 81 (6.94) 173 (6.98) 0.288
 Previous PCI/CABG, n (%) 95 (8.17) 204 (8.23) 0.312
Laboratory data    
 TC (mmol/L) 3.96 ± 1.06 4.07 ± 1.10 0.004
 HDL-C (mmol/L) 1.05 ± 0.87 1.09 ± 0.58 0.193
 LDL-C (mmol/L) 2.32 ± 0.85 2.44 ± 0.94 0.000
 TG (mmol/L) 1.75 ± 1.32 1.57 ± 1.15 0.000
 sST2 19.98 ± 13.97 18.43 ± 13.73 0.000
 Aspirin, n (%) 1085 (93.29) 2330 (94.03) 0.591
 ACEI, n (%) 537 (46.17) 966 (38.98) 0.000
 β-blocker, n (%) 632 (54.34) 1189 (47.98) 0.039
 Statins, n (%) 1097 (94.33) 2345 (94.63) 0.918
CAD classification    
 SAP 285 (24.51) 614 (24.78) 0.065
 ACS 954 (82.03) 1788 (72.15) 0.000